Sfondo Header
L'angolo del dottorino
Search the site... Advanced search

Cognitive Therapy (CT)

Cognitive therapy (CT), developed in the 1960s by Aaron T. Beck, is one of the most influential and extensively studied psychotherapeutic models for the treatment of depression. It forms the theoretical foundation of cognitive-behavioral therapy (CBT), but can also be applied as a standalone treatment primarily focused on the identification and modification of dysfunctional thoughts that fuel emotional distress.


The core assumption of CT is that depressive symptoms are sustained by systematic thinking errors and negative cognitive schemas about the self, the world, and the future. Through therapy, patients learn to recognize and reframe these distorted automatic thoughts, gradually regaining a more balanced and adaptive perspective of reality.

Beck’s Cognitive Model

According to Beck, depression is underpinned by a negative cognitive triad: individuals view themselves as inadequate or unworthy, the world as hostile or unfair, and the future as hopeless. These deeply rooted beliefs, or dysfunctional cognitive schemas, are triggered by stressful events and give rise to automatic negative thoughts—fast, distorted, and often unconscious.


These thoughts arise not from rational deliberation but from recurrent cognitive biases, including:


These cognitive distortions perpetuate depression by generating dysphoric emotions and avoidance or withdrawal behaviors. Treatment aims to increase awareness of these thought patterns, assess their validity, and replace them with more realistic and helpful interpretations.

Structure and Main Techniques

CT follows a brief, manualized, and goal-oriented format, usually consisting of 12–20 weekly sessions. Key techniques include:


Each session follows a structured format (agenda, homework review, core discussion, summary), with the goal of fostering patient autonomy and promoting continued use of cognitive skills after therapy ends.

Clinical Indications

Cognitive therapy is indicated for mild to moderate major depression, particularly in individuals with a prominent negative thinking style and ruminative tendencies. It can be used as an alternative to pharmacotherapy in mild cases or as a combined treatment in moderate to severe depression.


It is especially effective in patients who:


It is also used in the prevention of relapse among patients with recurrent depression, as part of long-term maintenance programs.

Effectiveness and Guidelines

CT is one of the most empirically validated psychotherapeutic approaches in scientific literature. Its techniques have been included in hundreds of randomized controlled trials and several meta-analyses confirming its clinical efficacy in reducing depressive symptoms, preventing relapse, and improving quality of life.

The NICE guidelines recommend CT (or CBT) as a first-line psychological treatment for mild and moderate depression, while the APA and CANMAT also endorse its use in more severe forms in conjunction with pharmacological treatment.


A key advantage is its long-lasting therapeutic effect: many patients maintain improvements even after therapy ends, thanks to their acquisition of self-analysis and cognitive regulation skills.

Final Considerations

Cognitive therapy is a solid, structured, and change-oriented model that targets the dysfunctional thought processes underlying depression. Its efficacy, clear methodology, and pragmatic focus make it a valuable tool in clinical management—either alone or integrated with other strategies.


More broadly, CT is not just a therapeutic intervention, but also a psychoeducational model that promotes autonomy, awareness, and emotional resilience in individuals affected by depressive disorders.

    References
  1. Beck AT et al. Cognitive therapy of depression. New York: Guilford Press; 1979.
  2. Hollon SD et al. Cognitive therapy and medication in the treatment and prevention of depression. Depress Anxiety. 2005;22(4):204–214.
  3. Butler AC et al. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17–31.
  4. Cuijpers P et al. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. World Psychiatry. 2013;12(3):307–317.
  5. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57(3):414–419.
  6. Driessen E et al. The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression. Am J Psychiatry. 2010;167(6):734–741.
  7. National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management. NICE guideline [NG222]. 2022.
  8. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. 2010.
  9. Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the management of major depressive disorder in adults. Can J Psychiatry. 2016;61(9):510–523.
  10. Beck JS. Cognitive behavior therapy: basics and beyond. New York: Guilford Press; 2011.